Cartherics had announced a significant leadership transition, appointing biotechnology executive and company co-founder Dr Ian Nisbet as Chief Executive Officer as the Melbourne-based cell therapy developer prepares for its next phase of growth.
Cartherics appoints Dr Ian Nisbet as CEO as the company accelerates toward clinical trials
December 1, 2025 Australian Biotech
Latest Video
New Stories
-
Cartherics appoints Dr Ian Nisbet as CEO as the company accelerates toward clinical trials
December 1, 2025 - - Australian Biotech -
Australian company reports high response rate in trial of off-the-shelf CAR-T therapy
December 1, 2025 - -
Melbourne showcases its health and biomedical strength as leaders gather for National Precincts Summit
December 1, 2025 - - Australian Biotech -
Pharmac to expand emergency medicine access for rural and remote communities
December 1, 2025 - - Latest News -
Tetratherix joint venture secures Alcon partnership to accelerate ophthalmic biomaterials
December 1, 2025 - - Australian Biotech -
MSD to bring vaccine distribution back in-house after 40-year partnership
December 1, 2025 - - Latest News -
New PBS listing offers fresh hope for Australians living with debilitating skin condition
December 1, 2025 - - Latest News
